{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:53:25Z","timestamp":1791939205982,"version":"4.3.4"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.otc.2025.01.006","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T19:58:23Z","timestamp":1743105503000},"page":"415-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pepsin, Mucosal Injury, and Pathophysiology of Non-acid Reflux"],"prefix":"10.1016","volume":"58","author":[{"given":"Tina L.","family":"Samuels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib1","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1111\/jgh.16017","article-title":"A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: a systematic review and meta-analysis","volume":"37","author":"Simadibrata","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.otc.2025.01.006_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9105814","article-title":"Meta-analysis of proton pump inhibitors in the treatment of pharyngeal reflux disease","volume":"2022","author":"Jin","year":"2022","journal-title":"Comput Math Methods Med"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jvoice.2019.05.005","article-title":"Proton pump inhibitors for the treatment of laryngopharyngeal reflux. A systematic review","volume":"34","author":"Spantideas","year":"2020","journal-title":"J Voice"},{"issue":"19","key":"10.1016\/j.otc.2025.01.006_bib4","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.3390\/jcm12196116","article-title":"Efficacy of tegoprazan in patients with laryngopharyngeal reflux disease: a preliminary feasibility study","volume":"12","author":"Jeon","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.otc.2025.01.006_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000475658","article-title":"Factors associated with potassium-competitive acid blocker non-response in patients with proton pump inhibitor-refractory gastroesophageal reflux disease","volume":"95","author":"Okuyama","year":"2017","journal-title":"Digestion"},{"issue":"9","key":"10.1016\/j.otc.2025.01.006_bib6","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/apt.12693","article-title":"Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients","volume":"39","author":"Hvid-Jensen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3390\/ph15050517","article-title":"Possible association between the use of proton pump inhibitors and H(2) receptor antagonists, and esophageal cancer: a nested case-control study using a Korean National Health Screening Cohort","volume":"15","author":"Choi","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib8","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00535-022-01930-3","article-title":"Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy","volume":"57","author":"Holmberg","year":"2022","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.otc.2025.01.006_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.101585","article-title":"Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer","volume":"62","author":"Brusselaers","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.otc.2025.01.006_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.canep.2018.02.004","article-title":"Maintenance proton pump inhibition therapy and risk of oesophageal cancer","volume":"53","author":"Brusselaers","year":"2018","journal-title":"Cancer Epidemiol"},{"issue":"10","key":"10.1016\/j.otc.2025.01.006_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/gut.2005.087668","article-title":"Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring","volume":"55","author":"Mainie","year":"2006","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gassur.2005.09.005","article-title":"Gastroesophageal and pharyngeal reflux detection using impedance and 24-hour pH monitoring in asymptomatic subjects: defining the normal environment","volume":"10","author":"Oelschlager","year":"2006","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib13","first-page":"184","article-title":"Laryngopharyngeal reflux: diagnosis, treatment, and latest research","volume":"18","author":"Campagnolo","year":"2014","journal-title":"Int Arch Otorhinolaryngol"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2025.01.006_bib14","first-page":"1","article-title":"Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010","volume":"33","author":"Pearson","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/nyas.13729","article-title":"Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration","volume":"1434","author":"Johnston","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.otc.2025.01.006_bib16","article-title":"Reflux revisited: advancing the role of pepsin","volume":"2012","author":"Bardhan","year":"2012","journal-title":"Int J Otolaryngol"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0016-5085(69)80121-6","article-title":"Role of acid and pepsin in acute experimental esophagitis","volume":"56","author":"Goldberg","year":"1969","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2025.01.006_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00004836-198606001-00006","article-title":"Experimental esophagitis in a rabbit model. Clinical relevance","volume":"8","author":"Johnson","year":"1986","journal-title":"J Clin Gastroenterol"},{"issue":"11","key":"10.1016\/j.otc.2025.01.006_bib19","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1111\/j.1572-0241.2001.05260.x","article-title":"The role of pepsin in acid injury to esophageal epithelium","volume":"96","author":"Tobey","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10620-006-3129-8","article-title":"Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats","volume":"51","author":"Nagahama","year":"2006","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib21","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MLG.0b013e31804154c3","article-title":"Activity\/stability of human pepsin: implications for reflux attributed laryngeal disease","volume":"117","author":"Johnston","year":"2007","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib22","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/000348940711601211","article-title":"Receptor-mediated uptake of pepsin by laryngeal epithelial cells","volume":"116","author":"Johnston","year":"2007","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"9","key":"10.1016\/j.otc.2025.01.006_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/000348940911800913","article-title":"Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells","volume":"118","author":"Johnston","year":"2009","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8","key":"10.1016\/j.otc.2025.01.006_bib24","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/000348941011900808","article-title":"Rationale for targeting pepsin in the treatment of reflux disease","volume":"119","author":"Johnston","year":"2010","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227408","article-title":"Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation","volume":"15","author":"Niu","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib26","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1053\/j.gastro.2009.07.055","article-title":"Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury","volume":"137","author":"Souza","year":"2009","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.otc.2025.01.006_bib27","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2016.5657","article-title":"Association of acute gastroesophageal reflux disease with esophageal histologic changes","volume":"315","author":"Dunbar","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.otc.2025.01.006_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coph.2017.10.004","article-title":"A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2\u03b1: a potential role for targeting HIF-2\u03b1 to prevent and treat reflux esophagitis","volume":"37","author":"Souza","year":"2017","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOO.0000000000000664","article-title":"Pepsin in gastroesophageal and extraesophageal reflux: molecular pathophysiology and diagnostic utility","volume":"28","author":"Samuels","year":"2020","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2025.01.006_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/1475636031000101246","article-title":"Inhibition of human pepsin and gastricsin by alpha2-macroglobulin","volume":"18","author":"Athauda","year":"2003","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib31","doi-asserted-by":"crossref","first-page":"G571","DOI":"10.1152\/ajpgi.00454.2009","article-title":"Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis","volume":"298","author":"Rieder","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib32","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1038\/s41598-018-21334-9","article-title":"Predictive biomarkers of gastroesophageal reflux disease and Barrett\u2019s esophagus in world trade center exposed firefighters: a 15 Year longitudinal study","volume":"8","author":"Haider","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12876-021-01707-7","article-title":"Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study","volume":"21","author":"Zavala-Solares","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.otc.2025.01.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156568","article-title":"Pepsin-mediated inflammation in laryngopharyngeal reflux via the ROS\/NLRP3\/IL-1\u03b2 signaling pathway","volume":"178","author":"Tan","year":"2024","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.otc.2025.01.006_bib35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/rccm.200706-895OC","article-title":"The mucosal immune response to laryngopharyngeal reflux","volume":"177","author":"Rees","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.otc.2025.01.006_bib36","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1080\/00365520410006729","article-title":"Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease","volume":"39","author":"Yoshida","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"82\u201383","key":"10.1016\/j.otc.2025.01.006_bib37","first-page":"482","article-title":"Interleukin 8 and 1beta and RANTES levels in esophageal mucosa predict recurrence of endoscopy-negative gastroesophageal reflux disease","volume":"55","author":"Isomoto","year":"2008","journal-title":"Hepato-Gastroenterology"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib38","first-page":"71","article-title":"Cytokine-induced neutrophil accumulation in the pathogenesis of acute reflux esophagitis in rats","volume":"16","author":"Yamaguchi","year":"2005","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.otc.2025.01.006_bib39","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1572-0241.2004.04110.x","article-title":"Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease","volume":"99","author":"Isomoto","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.otc.2025.01.006_bib40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1572-0241.2003.07303.x","article-title":"Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis","volume":"98","author":"Isomoto","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50360-4","article-title":"Pepsin triggers neutrophil migration across acid damaged lung epithelium","volume":"9","author":"Hurley","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.otohns.2009.08.022","article-title":"Pepsin as a causal agent of inflammation during nonacidic reflux","volume":"141","author":"Samuels","year":"2009","journal-title":"Otolaryngology-Head Neck Surg (Tokyo)"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib43","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/alr.22685","article-title":"Pepsin exposure in a non-acidic environment upregulates mucin 5AC (MUC5AC) expression via matrix metalloproteinase 9 (MMP9)\/nuclear factor \u03baB (NF-\u03baB) in human airway epithelial cells","volume":"11","author":"Choi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/lary.29749","article-title":"Association of pepsin with inflammatory signaling and effusion viscosity in pediatric otitis media","volume":"132","author":"Samuels","year":"2022","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.otc.2025.01.006_bib45","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/gutjnl-2016-312595","article-title":"Hypoxia-inducible factor-2\u03b1 plays a role in mediating oesophagitis in GORD","volume":"66","author":"Huo","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib46","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1152\/japplphysiol.91517.2008","article-title":"Role of ATP in the ROS-mediated laryngeal airway hyperreactivity induced by laryngeal acid-pepsin insult in anesthetized rats","volume":"106","author":"Tsai","year":"2009","journal-title":"J Appl Physiol"},{"issue":"10","key":"10.1016\/j.otc.2025.01.006_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/000348941312201006","article-title":"Curcumin and anthocyanin inhibit pepsin-mediated cell damage and carcinogenic changes in airway epithelial cells","volume":"122","author":"Samuels","year":"2013","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.otc.2025.01.006_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.115196","article-title":"The interaction of the green tea polyphenol (catechin) with pepsin: insights from spectroscopic to molecular dynamics studies","volume":"326","author":"Raeessi-babaheydari","year":"2021","journal-title":"J Mol Liq"},{"issue":"3","key":"10.1016\/j.otc.2025.01.006_bib49","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.foodchem.2006.03.020","article-title":"Effects of tea polyphenols on the activities of \u03b1-amylase, pepsin, trypsin and lipase","volume":"101","author":"He","year":"2007","journal-title":"Food Chem"},{"issue":"11","key":"10.1016\/j.otc.2025.01.006_bib50","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1016\/j.sjbs.2021.06.090","article-title":"The dual impact of Jordanian Ephedra alte for inhibiting pepsin and treating microbial infections","volume":"28","author":"Salman","year":"2021","journal-title":"Saudi J Biol Sci"},{"key":"10.1016\/j.otc.2025.01.006_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.122281","article-title":"Exploration of binding mechanism of apigenin to pepsin: spectroscopic analysis, molecular docking, enzyme activity and antioxidant assays","volume":"290","author":"Guo","year":"2023","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"key":"10.1016\/j.otc.2025.01.006_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119442","article-title":"Multi-spectral techniques and molecular docking to investigation of the interaction between ferulic acid and pepsin","volume":"251","author":"Zhu","year":"2021","journal-title":"Spectrochim Acta Mol Biomol Spectrosc"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2036.2000.00759.x","article-title":"Review article: alginate-raft formulations in the treatment of heartburn and acid reflux","volume":"14","author":"Mandel","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow020","article-title":"Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis","volume":"30","author":"Leiman","year":"2017","journal-title":"Dis Esophagus"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00405-008-0708-7","article-title":"The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux","volume":"266","author":"McGlashan","year":"2009","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib56","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cgh.2013.04.046","article-title":"An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease","volume":"11","author":"Rohof","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/apt.12857","article-title":"Gaviscon Double Action Liquid (antacid & alginate) is more effective than antacid in controlling post-prandial oesophageal acid exposure in GERD patients: a double-blind crossover study","volume":"40","author":"De Ruigh","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.otc.2025.01.006_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apt.15884","article-title":"Duration of adhesion of swallowed alginates to distal oesophageal mucosa: implications for topical therapy of oesophageal diseases","volume":"52","author":"Sonmez","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.otc.2025.01.006_bib59","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/lio2.1102","article-title":"Amprenavir inhibits pepsin-mediated laryngeal epithelial disruption and E-cadherin cleavage in vitro","volume":"8","author":"Samuels","year":"2023","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"9","key":"10.1016\/j.otc.2025.01.006_bib60","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.3390\/ijms24097932","article-title":"Topical alginate protection against pepsin-mediated esophageal damage: E-cadherin proteolysis and matrix metalloproteinase induction","volume":"24","author":"Samuels","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.otc.2025.01.006_bib61","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.3390\/ijms24076765","article-title":"The protease inhibitor amprenavir protects against pepsin-induced esophageal epithelial barrier disruption and cancer-associated changes","volume":"24","author":"Blaine-Sauer","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib62","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/ajg.2011.102","article-title":"Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease","volume":"106","author":"Jovov","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib63","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00109-021-02166-z","article-title":"Matrix metalloproteinase-7 induces E-cadherin cleavage in acid-exposed primary human pharyngeal epithelial cells via the ROS\/ERK\/c-Jun pathway","volume":"100","author":"Im","year":"2022","journal-title":"J Mol Med (Berl)"},{"issue":"21","key":"10.1016\/j.otc.2025.01.006_bib64","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.3390\/ijms20215276","article-title":"Role of matrix metalloproteinases 7 in the pathogenesis of laryngopharyngeal reflux: decreased E-cadherin in acid exposed primary human pharyngeal epithelial cells","volume":"20","author":"Im","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib65","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1007\/s00405-021-06997-x","article-title":"The integrity and barrier function of porcine vocal fold epithelium: its susceptibility to damage by deoxycholic acid compared with pepsin","volume":"278","author":"Lou","year":"2021","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib66","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/lary.30087","article-title":"Alginates for protection against pepsin-acid induced aerodigestive epithelial barrier disruption","volume":"132","author":"Samuels","year":"2022","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib67","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/lary.21776","article-title":"Evidence of extraesophageal reflux in idiopathic subglottic stenosis","volume":"121","author":"Blumin","year":"2011","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib68","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jss.2013.06.011","article-title":"Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation","volume":"185","author":"Davis","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.otc.2025.01.006_bib69","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.12659\/MSM.915628","article-title":"Gastric acid and pepsin work together in simulated gastric acid inhalation leading to pulmonary fibrosis in rats","volume":"25","author":"Chen","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.otc.2025.01.006_bib70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12935-019-0772-7","article-title":"Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma","volume":"19","author":"Tan","year":"2019","journal-title":"Cancer Cell Int"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168269","article-title":"The in vitro effect of acidic-pepsin on nuclear factor KappaB activation and its related oncogenic effect on normal human hypopharyngeal cells","volume":"11","author":"Sasaki","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/lary.28636","article-title":"RNA sequencing reveals cancer-associated changes in laryngeal cells exposed to non-acid pepsin","volume":"131","author":"Samuels","year":"2021","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2025.01.006_bib73","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0194599813517862","article-title":"Chronic pepsin exposure promotes anchorage-independent growth and migration of a hypopharyngeal squamous cell line","volume":"150","author":"Kelly","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2478\/raon-2014-0020","article-title":"Higher levels of total pepsin and bile acids in the saliva as a possible risk factor for early laryngeal cancer","volume":"49","author":"Sereg-Bahar","year":"2015","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0194599820938654","article-title":"Relationship between pepsin expression and dysplasia grade in patients with vocal cord leukoplakia","volume":"164","author":"Chen","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.otc.2025.01.006_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152336","article-title":"Extra-esophageal pepsin from stomach refluxate promoted tonsil hypertrophy","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.otc.2025.01.006_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.885537","article-title":"The oxidative damage and inflammation mechanisms in GERD-induced Barrett's esophagus","volume":"10","author":"Han","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"23","key":"10.1016\/j.otc.2025.01.006_bib78","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1158\/0008-5472.CAN-09-2518","article-title":"In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib79","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/gut.2006.103697","article-title":"Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus","volume":"56","author":"Dvorak","year":"2007","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2020.102681","article-title":"Association of pepsin and DNA damage in laryngopharyngeal reflux-related vocal fold polyps","volume":"41","author":"Dai","year":"2020","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"10.1016\/j.otc.2025.01.006_bib81","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/onc.2013.49","article-title":"Aberrant IKK\u03b1 and IKK\u03b2 cooperatively activate NF-\u03baB and induce EGFR\/AP1 signaling to promote survival and migration of head and neck cancer","volume":"33","author":"Nottingham","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.otc.2025.01.006_bib82","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.3390\/ijms22084275","article-title":"Pepsin promotes activation of epidermal growth factor receptor and downstream oncogenic pathways, at slightly acidic and neutral pH, in exposed hypopharyngeal cells","volume":"22","author":"Doukas","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.otc.2025.01.006_bib83","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00405-018-5254-3","article-title":"Heat shock protein 70 is induced by pepsin via MAPK signaling in human nasal epithelial cells","volume":"276","author":"Wang","year":"2019","journal-title":"Eur Arch Oto-Rhino-Laryngol"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/000348940611500108","article-title":"Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease","volume":"115","author":"Johnston","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"10.1016\/j.otc.2025.01.006_bib85","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archsurg.142.6.554","article-title":"Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery","volume":"142","author":"Oh","year":"2007","journal-title":"Arch Surg"},{"key":"10.1016\/j.otc.2025.01.006_bib86","doi-asserted-by":"crossref","DOI":"10.1177\/10732748211004883","article-title":"The early diagnostic value of serum interleukin-8 in esophagogastric junction adenocarcinoma","volume":"28","author":"Li","year":"2021","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bjorl.2022.10.050","article-title":"Diagnostic utility of salivary pepsin in laryngopharyngeal reflux: a systematic review and meta-analysis","volume":"89","author":"Jing","year":"2023","journal-title":"Braz J Otorhinolaryngol"},{"issue":"32","key":"10.1016\/j.otc.2025.01.006_bib88","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026756","article-title":"Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: a systemic review and meta-analysis","volume":"100","author":"Guo","year":"2021","journal-title":"Medicine (Baltim)"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib89","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0194599819827488","article-title":"Evaluation and management of laryngopharyngeal reflux disease: state of the art review","volume":"160","author":"Lechien","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.otc.2025.01.006_bib90","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jvoice.2021.04.009","article-title":"The controversy of pepsinogen A\/pepsin A in detecting extra-gastroesophageal reflux","volume":"37","author":"Rao","year":"2023","journal-title":"J Voice"},{"issue":"1-3","key":"10.1016\/j.otc.2025.01.006_bib91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-5793(03)00152-2","article-title":"The active site of pepsin is formed in the intermediate conformation dominant at mildly acidic pH","volume":"538","author":"Campos","year":"2003","journal-title":"FEBS Lett"},{"issue":"2","key":"10.1016\/j.otc.2025.01.006_bib92","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00609248","article-title":"Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man","volume":"35","author":"Ten Kate","year":"1988","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.otc.2025.01.006_bib93","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/j.ijporl.2015.10.034","article-title":"Investigation of pepsin in tears of children with laryngopharyngeal reflux disease","volume":"79","author":"Iannella","year":"2015","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"8","key":"10.1016\/j.otc.2025.01.006_bib94","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/01.mlg.0000172043.51871.d9","article-title":"Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux","volume":"115","author":"Knight","year":"2005","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2025.01.006_bib95","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/lary.31134","article-title":"The dubai definition and diagnostic criteria of laryngopharyngeal reflux: the IFOS consensus","volume":"134","author":"Lechien","year":"2024","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.otc.2025.01.006_bib96","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1002\/lary.31239","article-title":"Pepsin inhibitors prevent inflammation and loss of laryngeal barrier function in mice with gastroesophageal reflux","volume":"134","author":"Sales","year":"2024","journal-title":"Laryngoscope"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2025.01.006_bib97","first-page":"S1","article-title":"Oral and inhaled fosamprenavir reverses pepsin-induced damage in a laryngopharyngeal reflux mouse model","volume":"133 Suppl 1","author":"Johnston","year":"2023","journal-title":"Laryngoscope"},{"issue":"11","key":"10.1016\/j.otc.2025.01.006_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207090","article-title":"Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.otc.2025.01.006_bib99","article-title":"Inhaled fosamprenavir for laryngopharyngeal reflux: toxicology and fluid dynamics modeling","volume":"9","author":"Lesnick","year":"2024","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.otc.2025.01.006_bib100","unstructured":"U.S. Department of Health and Human Services. Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments (Docket No. FDA-2022-D-1385). U.S., Food and Drug Administration Center for Drug Evaluation and Research, 2022."}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666525000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666525000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:33:02Z","timestamp":1762216382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666525000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0030666525000064"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2025.01.006","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pepsin, Mucosal Injury, and Pathophysiology of Non-acid Reflux","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2025.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}